Evidence map›Paper›PMID 12813012›Full record

ReviewThe Journal of clinical investigation2003

Monogenic hypercholesterolemia: new insights in pathogenesis and treatment.

Daniel J Rader, Jonathan Cohen, Helen H Hobbs

Abstract readHistorical ArticleReview
In one paragraph

Review in The Journal of clinical investigation, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 180 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Personalized genomic disease risk of volunteers.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Therapeutic Gene Editing in Dyslipidemias.Reviews in cardiovascular medicine · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Current RNA strategies in treating cardiovascular diseases.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Review

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daniel J RaderDepartment of Medicine and Center for Experimental Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Jonathan Cohen
Helen H Hobbs

Funding

TRANSCRIPTIONAL REGULATION OF LDL RECEPTOR PROMOTERP01HL020948 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI GOLDSTEIN, JOSEPH L · 1985 to 2021
$103.1M
VECTOR COREP01HL059407 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LIMBERIS, MARIA P. · 1999 to 2019
$35.6M
ZDV VS ZDV + DDL VS ZDV + DDL + NVP IN ASYMPTOMATIC HIV PATIENTSM01RR000040 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 1985 to 2006
$21.1M
Oxidative Modifications of Proteins and Fibrinogen in AtherosclerosisP50HL070128 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2002 to 2006
$10.8M
Role of ABCG5 and ABCG8 in Sterol MetabolismR01HL072304 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI HOBBS, HELEN HASKELL · 2003 to 2025
$7.0M
Role of ABCG5 and ABCG8 in Sterol MetabolismR37HL072304 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI HOBBS, HELEN HASKELL · 2008 to 2017
$4.5M
HDL metabolism: Influence of extracellular lipasesR37HL055323 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI RADER, DANIEL JAMES · 2009 to 2018
$4.0M
High Density Lipoprotein Metabolism Influence of Extracellular PhospholipasesR01HL055323 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI RADER, DANIEL JAMES · 1996 to 2009
$3.0M
GENETIC DETERMINANTS OF PLASMA LIPOPROTEINSR01HL053917 · NHLBI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI COHEN, JONATHAN C · 1994 to 2002
$766k
NCRR NIH HHS M01 RR000040NCRR NIH HHS RR-00040NHLBI NIH HHS HHL-53917NHLBI NIH HHS HL-20948NHLBI NIH HHS HL-55323NHLBI NIH HHS HL-59407NHLBI NIH HHS HL-70128NHLBI NIH HHS HL-72304NHLBI NIH HHS P01 HL020948NHLBI NIH HHS P01 HL059407NHLBI NIH HHS P50 HL070128NHLBI NIH HHS R01 HL055323NHLBI NIH HHS R01 HL072304NHLBI NIH HHS R37 HL055323NHLBI NIH HHS R37 HL072304
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Apolipoprotein B-100Apolipoproteins BCoronary Artery DiseaseGenes, DominantGenes, RecessiveHistory, 20th CenturyHumansHyperlipoproteinemia Type IILipoproteins, LDLSitosterolsApolipoprotein B-100Apolipoproteins Bgamma-sitosterolLipoproteins, LDLSitosterols

Identifiers

PMID12813012
PMCPMC161432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.